PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
05-Mar-2026 US Pharmacy Market is Attribute to Reach CAGR of approximately 5-6% Revenues by 2029 Medi-Tech Insights
05-Mar-2026 Digital Biomarkers Market Executive Summary, Segmentation, Review, Trends, Opportunities, Growth, Demand and Forecast to 2030 Medi-Tech Insights
05-Mar-2026 Cantargia to Participate at Van Lanschot Kempen's Life Sciences Conference ACCESS Newswire
05-Mar-2026 Vicore Pharma Elevates Leadership Team Ahead of Key Clinical and Corporate Milestones ACCESS Newswire
05-Mar-2026 The New England Journal of Medicine Publishes First Data to Demonstrate the Potential for Disease Modification in Dravet Syndrome Businesswire
05-Mar-2026 Ironwood Pharmaceuticals to Participate in The Citizens Life Sciences Conference Businesswire
05-Mar-2026 OmniAb Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights Businesswire
05-Mar-2026 PepGen Reports Fourth Quarter and Year-End 2025 Financial Results and Recent Corporate Highlights Businesswire
05-Mar-2026 PepGen Announces Regulatory Updates on FREEDOM2 Businesswire
05-Mar-2026 Niagen Bioscience Reports 30% Year-Over-Year Net Sales Increase to $129.4 million, 103% Net Income Increase to $17.4 million or $0.22 Basic EPS in 2025 Businesswire
04-Mar-2026 Medincell to Participate in Leerink and Jefferies Miami Investor Conferences, March 8 – 11, 2026 Businesswire
04-Mar-2026 Arsenal Medical Announces First Patient Treated with ResQFoam for Life-Threatening Abdominal Bleeding Businesswire
04-Mar-2026 UCB and Antengene enter global license agreement for ATG-201, a B cell-depleting bispecific antibody UCB
04-Mar-2026 Microbot Medical® Aligns with Recently Adopted Policy of the Largest U.S.-Based Medical Association to Expand Protection for Healthcare Professionals from Ionizing Radiation Microbot Medical
04-Mar-2026 Astra Zeneca - Future Biogas: first anniversary of unsubsidised biomethane plant with carbon capture Astra Zeneca
04-Mar-2026 Theolytics Awarded €8 million in Horizon Europe 2025 Grant Funding to Advance Phase 2 Study of THEO-260 in Ovarian Cancer Theolytics
04-Mar-2026 CNX Therapeutics appoints Erin Federman as non-executive director CNX Therapeutics
04-Mar-2026 Innovation Investment Capital and Development Bank of Wales back Antiverse to accelerate AI-driven drug discovery in $9.3 million Series A fund round Innovation Investment Capital Limited Partnership (IIC)
04-Mar-2026 Children’s development set back years by Covid lockdowns, study reveals The University of East Anglia (UEA)
04-Mar-2026 BC Platforms launches next generation trusted research environment on AWS Marketplace BC Platforms